Evidence map›Paper›PMID 40704759›Full record

ReviewClinical microbiology reviews2025

The long reach of influenza and other respiratory viruses: from acute epithelial injury to post-viral lung disease.

Piotr P Janas, Christoforos Rozario, Christopher D Lucas, Pieter S Hiemstra, Jürgen Schwarze, Caroline Chauché

Abstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Challenges and opportunities in the management of severe pneumonia. Key concepts from the Seventh Annual Meeting of Spanish Experts 2025.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026
    Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Piotr P JanasCentre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh BioQuarter, Edinburgh, United Kingdom.ORCID 0000-0001-5422-258X
Christoforos RozarioDepartment of Life Sciences, Program in Biological Sciences, European University Cyprus, Nicosia, Cyprus.
Christopher D LucasCentre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh BioQuarter, Edinburgh, United Kingdom.ORCID 0000-0002-7523-0295
Pieter S HiemstraDepartment of Pulmonology, PulmoScience Lab, Leiden University Medical Center, Leiden, the Netherlands.ORCID 0000-0002-0238-5982
Jürgen SchwarzeCentre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh BioQuarter, Edinburgh, United Kingdom.ORCID 0000-0002-6899-748X
Caroline ChauchéCentre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh BioQuarter, Edinburgh, United Kingdom.ORCID 0000-0002-9127-4693

Funding

British Lung FoundationHorserace Betting Levy Board VET/2020 -1 EPDF 7
6 · The paper itself

Abstract

SUMMARYRespiratory viral infections cause extensive cell death in the lung epithelium, resulting from both direct viral action and exuberant immune responses. Recovery following viral infection requires rapid and coordinated repair programs, ensuring the replacement of the damaged tissue through proliferation, migration, and differentiation of respiratory epithelial progenitor cells. Viral infection and the resulting inflammatory milieu alter host gene expression. Notably, growing evidence indicates that these infections can induce long-term changes in epithelial progenitor cells, which persist even after the infection has resolved. These alterations may play a key role in the development of post-viral lung disease (PVLD). In this review, we discuss current knowledge regarding respiratory viral infections and how these may alter the gene expression and function of epithelial progeny cells arising from the surviving progenitors. We do so by exploring the influenza virus as an example and comparing it with what is known about other important respiratory viruses, such as respiratory syncytial virus (RSV), rhinovirus (HRV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). We highlight the impact of respiratory viral infection and ensuing inflammation on lung epithelial memory, considering the importance of viral strains, and discuss potential new therapeutic strategies that could maximize long-term lung health.

Indexed as

Influenza, HumanLung DiseasesRespiratory Tract InfectionsVirus DiseasesAnimalsCOVID-19Epithelial CellsHumansOrthomyxoviridaeRespiratory MucosaSARS-CoV-2influenzalung epithelial cellspost-viral lung diseaseprogenitor epithelial cellsPVLDrespiratory infectionrespiratory syncytial virusrespiratory virusesrhinovirusSARS-CoV-2

Identifiers

PMID40704759
PMCPMC12424396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.